Lazcluze ( Lazertinib ) in non-small cell lung cancer (NSCLC)
CPE point: 1 per event
This is an in-service training for the staff of St. Teresa's Hospital & St. Paul's Hospital
Date:
2026-09-24
Organising Institute:
St. Teresa's Hospital & St. Paul's Hospital
Speaker:
MPhil (Pharmacology & Pharmacy), Karie Chin, Scientific Advisor, Medical Affairs, Johnson & Johnson
Related CPE Activities: